Touchstone International Medical Science Co., Ltd. (SHA:688013)
China · Delayed Price · Currency is CNY 22.75
+0.43 (1.93%)
Sep 14, 2026, 3:00 PM CST
SHA:688013 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,831 | 3,842 | 1,396 | 1,671 | 1,556 | 2,035 | |
Market Cap Growth | -65.93% | 175.28% | -16.48% | 7.41% | -23.55% | -15.79% |
Enterprise Value | 1,710 | 3,515 | 968 | 1,272 | 1,150 | 1,622 |
Last Close Price | 22.75 | 46.62 | 16.18 | 18.86 | 17.14 | 22.26 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.19 | 45.11 | 26.90 | 35.33 | 36.02 | 49.14 |
PS Ratio | 6.45 | 11.76 | 5.13 | 6.59 | 6.71 | 9.52 |
PB Ratio | 3.70 | 6.79 | 2.40 | 2.92 | 3.06 | 3.97 |
P/TBV Ratio | 4.02 | 7.33 | 2.58 | 3.15 | 3.33 | 4.00 |
P/FCF Ratio | - | - | 121.71 | 25.90 | 569.75 | 39.31 |
P/OCF Ratio | 43.77 | 53.38 | 26.14 | 20.15 | 30.87 | 33.38 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.02 | 10.76 | 3.55 | 5.01 | 4.96 | 7.59 |
EV/EBITDA Ratio | 31.52 | 42.09 | 17.29 | 32.94 | 27.81 | 45.51 |
EV/EBIT Ratio | 41.69 | 48.70 | 20.88 | 43.01 | 34.57 | 57.08 |
EV/FCF Ratio | - | - | 84.39 | 19.71 | 421.12 | 31.33 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.27 | 0.09 | 0.00 | 0.00 | 0.00 | - |
Debt / EBITDA Ratio | 2.41 | 0.60 | 0.04 | 0.05 | 0.02 | - |
Debt / FCF Ratio | - | - | 0.18 | 0.03 | 0.35 | - |
Net Debt / Equity Ratio | -0.24 | -0.43 | -0.68 | -0.75 | -0.71 | -0.84 |
Net Debt / EBITDA Ratio | -2.28 | -2.92 | -7.02 | -11.08 | -8.74 | -12.09 |
Net Debt / FCF Ratio | 3.79 | 12.98 | -34.28 | -6.63 | -132.32 | -8.32 |
Asset Turnover | 0.44 | 0.50 | 0.43 | 0.43 | 0.43 | 0.42 |
Inventory Turnover | 2.61 | 3.66 | 3.79 | 3.56 | 3.34 | 3.48 |
Quick Ratio | 2.11 | 3.84 | 7.95 | 8.71 | 11.41 | 14.25 |
Current Ratio | 2.50 | 4.30 | 8.69 | 9.32 | 12.55 | 15.14 |
Return on Equity (ROE) | 9.49% | 14.85% | 9.00% | 8.76% | 8.46% | 8.47% |
Return on Assets (ROA) | 3.93% | 6.89% | 4.58% | 3.16% | 3.82% | 3.45% |
Return on Invested Capital (ROIC) | 9.90% | 25.32% | 26.44% | 20.10% | 27.32% | 30.44% |
Return on Capital Employed (ROCE) | 7.70% | 12.30% | 7.90% | 5.10% | 6.50% | 5.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.77% | 2.22% | 3.72% | 2.83% | 2.78% | 2.04% |
FCF Yield | -1.74% | -0.49% | 0.82% | 3.86% | 0.18% | 2.54% |
Dividend Yield | 6.40% | 2.79% | 6.18% | - | 1.46% | 0.90% |
Payout Ratio | 207.96% | 142.72% | 73.81% | 41.85% | 36.91% | 38.63% |
Buyback Yield / Dilution | 1.45% | -0.05% | 0.60% | -0.09% | -0.35% | -25.49% |
Total Shareholder Return | 7.85% | 2.73% | 6.77% | -0.09% | 1.11% | -24.59% |